Creating a sustainable and resilient pharma supply from raw materials to the patient

 Creating a sustainable and resilient pharma supply from raw materials to the patient
The pharma industry is 55 per cent more emission-intensive than the automotive industry, according to the report titled, Carbon footprint of the global pharmaceutical industry and relative impact of its major players.  At the same time regulators and society demand safe, affordable and accessible healthcare globally.
Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

Accelerate your Drug Development process with Lonza Engine™

Pharmtech

Speed and quality are key in pharmaceutical manufacturing. How can your equipment add value to your production process? Join the Lonza team to discover how the new Lonza Engine™ equipment portfolio is designed to support bioavailability enhancement, encapsulation and early-phase clinical development technologies.
Watch Now

Science or Hype? Navigating the Questions about Titanium Dioxide Safety

Pharmtech

In this webcast, experts will discuss the current status and assess the potential market impact for the pharmaceutical industry. The discussion will review the current legal situation and the position of the different regulatory bodies. Participants will learn about the science-based facts influencing the industry response and gain insight into the possible implications on the use of TiO2 in pharmaceutical products, as well as food supplements.
Watch Now

Pharma R&D Review: What Changed In 2018, What To Look Out For In 2019

pharmaintelligence

The drug R&D pipeline in 2019, and how it is changing
Watch Now

Patient-Preferred Trials

eyeforpharma

Clinical trial participants are no longer just numbers on a spreadsheet. They are customers, consumers, patients and people, with all their wonderful complexities, preferences and nuances. And they have a right to choose whether your trial is going to suit them.
Watch Now